Eli Lilly & Co. (LLY) Dividend Summary

Eli Lilly and Company discovers, develops, manufactures, and sells products in one significant business segment -pharmaceutical products. The company directs its research efforts primarily toward the search for products to diagnose, prevent and treat human diseases. The company also conducts research to find products to treat diseases in animals and to increase the efficiency of animal food production.

Last update 07/22/2010

Dividend Yield Summary

	2009	2008	2009	2010	2011	2012
Dividends	$1.96	$1.88	$0	$0	$0	$0
Price	$32.83	$33.75	$0	$0	$0	$0
Yield	5.97 %	5.57 %	0 %	0 %	0 %	0 %

Earnings Information

Next Report Date	10/21/2009
Estimated EPS (year)	$4.28
Estimated EPS (quarter)	$1.01
Estimated EPS Growth	2.63%
Payout Ratio	0.44%
Payout change vs. 5 year average	-0.06%

Dividend/Split History

Date	Amount Per Share/Split Ratio	Type
2010-06-10	$0.49000	Dividend
2010-03-10	$0.49000	Dividend
2009-12-10	$0.49000	Dividend
2009-09-10	$0.49000	Dividend
2009-03-10	$0.49000	Dividend
2008-12-10	$0.47000	Dividend
2008-09-10	$0.47000	Dividend
2008-02-13	$0.47000	Dividend
2007-11-13	$0.42500	Dividend
2007-08-13	$0.42500	Dividend
2007-05-11	$0.42500	Dividend
2007-02-13	$0.42500	Dividend
2006-11-13	$0.40000	Dividend
2006-08-11	$0.40000	Dividend
2006-05-11	$0.40000	Dividend
2006-02-13	$0.40000	Dividend
2005-11-10	$0.38000	Dividend
2005-08-11	$0.38000	Dividend
2005-05-11	$0.38000	Dividend
2005-02-11	$0.38000	Dividend

Company Profile

LILLY ELI & CO
Lilly Corporate Center
Indianapolis, IN 46285, USA
Phone: 317-276-2000
Fax: 317-276-4878
Web: www.lilly.com
Email:

Key Information

Sector:	Medical
Industry:	DRUGS
Analysts	21
Fiscal Year End:	December
Next Reported Fiscal Year:	2008
Last Reported Quarter:	6/30/2009

Management

Chmn.; C.E.O.; Dir.	Sidney Taurel
Presi.; C.O.O.; Dir.	John C. Lechleiter Ph.D.
Sr. V.P.; C.F.O.	Derica W. Rice
Sr. V.P.; Gen. Consl.	Robert A. Armitage
Dir.	Martin S. Feldstein Ph.D.

Competitors

SIC Code: 2834

Ticker	Company Name
JNJ	JOHNSON & JOHNS
PFE	PFIZER INC
GSK	GLAXOSMITHKLINE
SNY	SANOFI-SYNT-ADR
RHHBY	ROCHE HLDG LTD
NVS	NOVARTIS AG-ADR
AZN	ASTRAZENECA PLC

Eli Lilly & Co. LLY (NYSE) Financial Ratios

P/E
Current FY Estimate	7.67
Trailing 12 Months	7.41
PEG Ratio	2.92

EPS Growth
vs. Previous Year	13.13%
vs. Previous Quarter	-6.67%

Sales Growth
vs. Previous Year	2.76%
vs. Previous Quarter	4.87%

Price Ratios
Price/Book	4.41
Price/Cash Flow	6.76
Price/Sales	1.82

ROE
06/30/2009	52.78
03/30/2009	43.81
12/30/2008	35.11

ROA
06/30/2009	17.57
03/30/2009	16.91
12/30/2008	15.73

Current Ratio
06/30/2009	1.56
03/30/2009	1.39
12/30/2008	0.95

Quick Ratio
06/30/2009	1.14
03/30/2009	1.05
12/30/2008	0.76

Operating Margin
06/30/2009	23.37
03/30/2009	22.81
12/30/2008	21.59

Net Margin
06/30/2009	-7.82
03/30/2009	-8.84
12/30/2008	-10.17

Pre-Tax Margin
06/30/2009	-2.02
03/30/2009	-3.30
12/30/2008	-6.42

Book Value
06/30/2009	7.45
03/30/2009	6.72
12/30/2008	5.92

Inventory Turnover
06/30/2009	1.51
03/30/2009	1.69
12/30/2008	1.80

Debt-to-Equity
06/30/2009	0.78
03/30/2009	0.89
12/30/2008	0.69

Debt-to-Capital
06/30/2009	43.86
03/30/2009	47.07
12/30/2008	40.66

Quick Quote

Updated as of 4:00pm

Last Trade:	34.54
Trade Time:	4:00pm
Change:	0.00
Open:	N/A
High:	N/A
Low:	N/A
Volume:	0

Security Details

Exchange	NYSE
CUSIP
Split Date	-
Split Factor	2
Shares outstanding	1,149.02
Beta	0.79

Detailed Quote as of 09/10/2009

Price	$32.83
52 Week High	$46.82
52 Week Low	$27.47
Price Change (4 weeks)	$-2.49
Price Change (12 weeks)	$-0.45
Price Change (YTD)	$-18.48
Price Change (4 weeks) vs. S&P	$-5.45
Price Change (12 weeks) vs. S&P	$-11.47
Price Change (YTD) vs. S&P	$-27.18
Average Daily Volume (20 Days)	5,502,410
Market Capitalization	$37,722.40

Price History

Earning Announcement

Last Confirmation Date	2010-07-09
Next Earnings Announcement Date	2010-07-22
Earnings Quarter	Q2
Announcement Status	Confirmed

Investor Conference Call

Date	2010-07-22
Time	09:00:00
URL	Conference Call Information

Last Dividend Payout

Announcement Date	2010-04-19
Record Date	2010-05-14
Pay Date	2010-06-10
Amount Per Share	$0.49

Board Shareholder Meeting

First Quarter	2010-04-19
Second Quarter	2009-07-22
Third Quarter	2009-10-21
Fourth Quarter	2010-01-28